Author: GlobeNewswire

More than 30 million Americans at risk for Lyme disease exposure, which can result in severe neurological and other debilitating…

CAMBRIDGE, Mass., June 16, 2021 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing a…

STOUGHTON, Mass., June 16, 2021 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the…

DURHAM, N.C., June 16, 2021 (GLOBE NEWSWIRE) — Novan, Inc. (the “Company” or “Novan”) (NASDAQ: NOVN) today announced a proposed…

JSC Olainfarm has received announcements on substantial participation from Anna Emīlija Maligina, SIA “OLMAFARM” and SIA “FARMA FUND”. The received announcements…

NASHVILLE, Tenn., June 14, 2021 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused…

OXFORD, United Kingdom, June 14, 2021 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the…

TORONTO, June 14, 2021 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (“Acerus”) (TSX: ASP; OTCQB: ASPCF) today announced the voting results…

BLACKSBURG, Va., June 14, 2021 (GLOBE NEWSWIRE) — Landos Biopharma, Inc. (NASDAQ: LABP), a late clinical-stage biopharmaceutical company utilizing its…

TORONTO, June 14, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF, Frankfurt: 31R),…